Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Crypto Market Update: Bitcoin’s New High, Ethereum ETFs Outpace Bitcoin 5-to-1 August 16, 2025 Top 5 Small-cap Pharma Stocks of 2025 August 16, 2025 Westport Files Preliminary Short Form Base Shelf Prospectus To Replace Expired Base Shelf Prospectus August 16, 2025
Westport Files Preliminary Short Form Base Shelf Prospectus To Replace Expired Base Shelf Prospectus August 16, 2025